Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
- 1 January 1999
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 16 (10) , 1576-1581
- https://doi.org/10.1023/a:1018908705446
Abstract
Purpose. To investigate the potential of chitosan nanoparticles as a system for improving the systemic absorption of insulin following nasal instillation. Methods. Insulin-loaded chitosan nanoparticles were prepared by ionotropic gelation of chitosan with tripolyphosphate anions. They were characterized for their size and zeta potential by photon correlation spectroscopy and laser Doppler anemometry, respectively. Insulin loading and release was determined by the microBCA protein assay. The ability of chitosan nanoparticles to enhance the nasal absorption of insulin was investigated in a conscious rabbit model by monitoring the plasma glucose levels. Results. Chitosan nanoparticles had a size in the range of 300−400 nm, a positive surface charge and their insulin loading can be modulated reaching values up to 55% [insulin/nanoparticles (w/w): 55/100]. Insulin association was found to be highly mediated by an ionic interaction mechanism and its release in vitro occurred rapidly in sink conditions. Chitosan nanoparticles enhanced the nasal absorption of insulin to a greater extent than an aqueous solution of chitosan. The amount and molecular weight of chitosan did not have a significant effect on insulin response. Conclusions. Chitosan nanoparticles are efficient vehicles for the transport of insulin through the nasal mucosa.Keywords
This publication has 9 references indexed in Scilit:
- Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2)Journal of Controlled Release, 1998
- Optimization of systemic nasal drug delivery with pharmaceutical excipientsAdvanced Drug Delivery Reviews, 1998
- Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and VaccinesPharmaceutical Research, 1997
- Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)Pharmaceutical Research, 1994
- Chitosan as a Novel Nasal Delivery System for Peptide DrugsPharmaceutical Research, 1994
- Effects of insulin and nasal absorption enhancers on ciliary activityInternational Journal of Pharmaceutics, 1993
- Protease inhibitors and penetration enhancers as approaches to modify peptide absorptionJournal of Controlled Release, 1990
- Analysis of Structural Requirements for the Absorption of Drugs and Macromolecules from the Nasal CavityJournal of Pharmaceutical Sciences, 1987
- Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gelJournal of Pharmacy and Pharmacology, 1985